Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HTR1B | P28222 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | HTR1D | P28221 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10711044 | 1.00 | KCNA3 (0.56) | KCNA3PKMRECQLKDM4EHTR1B | |
| SCHEMBL22297235 | 1.00 | KCNA3 (0.56) | KCNA3PKMRECQLKDM4EHTR1B | |
| SCHEMBL11134448 | 1.00 | KCNA3 (0.56) | KCNA3PKMRECQLKDM4EHTR1B | |
| SCHEMBL1535614 | 1.00 | KCNA3 (0.56) | KCNA3PKMRECQLKDM4EHTR1B | |
| SCHEMBL213738 | 0.93 | KCNA3 (0.64) | KCNA3PKMRECQLHTR1BALDH1A1 | |
| SCHEMBL22297588 | 0.92 | KDM4E (0.52) | KCNA3PKMRECQLKDM4EALDH1A1 | |
| SCHEMBL30507510 | 0.92 | KCNA3 (0.64) | KCNA3PKMRECQLHTR1BALDH1A1 | |
| SCHEMBL28279031 | 0.91 | KCNA3 (0.61) | KCNA3PKMRECQLHTR1BALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL3997746 | 0.91 | KCNA3 (0.61) | KCNA3PKMRECQLHTR1BALDH1A1 | |
| SCHEMBL4824476 | 0.91 | ALDH1A1 (0.62) | KCNA3PKMRECQLKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115449055-A | Conjugated microporous polymer and application thereof as solid electrolyte in lithium ion battery | 南京理工大学 | 2022-12-09 | — | — | CN | claimed |
| CN-101831054-B | Method for distinguishing fungi and bacteria | CHINESE ACAD INST CHEMISTRY | 2011-11-16 | — | — | CN | claimed |
| CN-101831054-A | Method for distinguishing fungi and bacteria | CHINESE ACAD INST CHEMISTRY | 2010-09-15 | — | — | CN | claimed |
| EP-1594857-A2 | N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI-CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-16 | — | — | EP | claimed |
| WO-2004069133-A2 | N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-19 | — | — | WO | claimed |
| US-12419561-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| CN-119546740-A | Cleaning agent for hard surfaces | 轨迹方案IPCO有限责任公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-3995544-B1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE | SHINETSU CHEMICAL CO (JP) | 2024-12-04 | — | — | EP | disclosed |
| CN-114431864-B | Bioelectrode composition, bioelectrode, and bioelectrode manufacturing method | 信越化学工业株式会社 | 2024-12-03 | — | — | CN | disclosed |
| US-20240243327-A1 | NAPHTHALENE DIIMIDE COMPOUND AND REDOX FLOW BATTERY CONTAINING THE SAME | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-07-18 | — | — | US | disclosed |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | ARVINAS OPERATIONS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| CN-116947903-A | Inhibitors of complement factors and uses thereof | 安尼艾克松股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-1458707-A2 | NEW COMPOUNDS | AstraZeneca AB (SE) | 2004-09-22 | — | — | EP | disclosed |
| WO-2004069133-A2 | N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-19 | — | — | WO | disclosed |
| EP-0735403-B1 | Liquid crystal orienting agent | JSR CORP (JP) | 2004-03-17 | — | — | EP | disclosed |
| WO-2003053330-A2 | USE OF OXINDOLE DERIVATIVES IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER’S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3 | ASTRAZENECA AB (SE) | 2003-07-03 | — | — | WO | disclosed |
| US-5700860-A | Liquid crystal orienting agent | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| EP-0735403-A1 | Liquid crystal orienting agent | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
| EP-0176076-B1 | METHOD FOR THE PREPARATION OF CROWN ETHERS | Consortium für elektrochemische Industrie GmbH (DE) | 1988-09-14 | — | — | EP | disclosed |
| EP-0176076-A1 | Method for the preparation of crown ethers | Consortium für elektrochemische Industrie GmbH (DE) | 1986-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240243327-A1 | NAPHTHALENE DIIMIDE COMPOUND AND REDOX FLOW BATTERY CONTAINING THE SAME | IDH2, NDUFV2, NDUFS8 | KCNA3 1615/4885PKM 2221/4885RECQL 284/4885 |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | CRBN, MDM2, VHL | KCNA3 4718/4885PKM 3048/4885RECQL 1851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.